SB18-023
Promote Off-label Use Pharmaceutical Products
Concerning the promotion of the off-label use of pharmaceutical products.
Session:
2018 Regular Session
Subject:
Bill Summary
Health Care & Health Insurance
The bill allows a pharmaceutical manufacturer or its representative to promote the off-label use of a prescription drug, biological product, or device approved by the United States food and drug administration.
(Note: This summary applies to this bill as introduced.)